April 26, 2013

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Report updates impact of hypoglycemia in diabetes

An update of the current state of knowledge about the impact of hypoglycemia on patients with diabetes reviews outcomes, strategies to prevent hypoglycemia, and current knowledge gaps, and has been published in the May issue of Diabetes Care.
× close
An update of the current state of knowledge about the impact of hypoglycemia on patients with diabetes reviews outcomes, strategies to prevent hypoglycemia, and current knowledge gaps, and has been published in the May issue of Diabetes Care.

(HealthDay)—An update of the current state of knowledge about the impact of hypoglycemia on patients with diabetes reviews outcomes, strategies to prevent hypoglycemia, and current knowledge gaps, and has been published in the May issue of Diabetes Care.

Elizabeth R. Seaquist, M.D., from the University of Minnesota in Minneapolis, and colleagues convened a workgroup consisting of members of the American Diabetes Association and The Endocrine Society with expertise on hypoglycemia to review the more recent evidence about the impact of hypoglycemia on patients with diabetes.

The researchers reconfirmed definitions of hypoglycemia in diabetes. They also reviewed the implications of hypoglycemia on short- and long-term outcomes for particular patient populations, and considered the implications of hypoglycemia on treatment outcomes. In addition, they discussed strategies to prevent hypoglycemia and clinical recommendations for those at risk for the condition. Lastly, the authors identified current in the study of hypoglycemia.

"If patients are to benefit from the reduction in that follows from achieving near-normal levels of glycemia, additional research will be necessary to prevent them from experiencing hypoglycemia and hypoglycemia-associated autonomic failure," Seaquist and colleagues write.

The workgroup meeting was funded by educational grants or sponsorships from several pharmaceutical companies to the .

Load comments (0)